In April, NICE rejected two of the only symptom management treatments specifically licensed for MS.
We know that access to these treatments is a priority for many people with MS and we have anecdotal evidence that with these treatments unavailable, some people are turning to alternative or unlicensed options.
We need to hear from you to make sure we understand the full picture! Take our survey Click here